Mutational analysis of the subgroup A avian sarcoma and leukosis virus putative fusion peptide domain.
Short hydrophobic regions referred to as fusion peptide domains (FPDs) at or near the amino terminus of the membrane-anchoring subunit of viral glycoproteins are believed to insert into the host membrane during the initial stage of enveloped viral entry. Avian sarcoma and leukosis viruses (ASLV) are unusual among retroviruses in that the region in the envelope glycoprotein (EnvA) proposed to be the FPD is internal and contains a centrally located proline residue. To begin analyzing the function of this region of EnvA, 20 substitution mutations were introduced into the putative FPD. The mutant envelope glycoproteins were evaluated for effects on virion incorporation, receptor binding, and infection. Interestingly, most of the single-substitution mutations had little effect on any of these processes. In contrast, a bulky hydrophobic substitution for the central proline reduced viral titers 15-fold without affecting virion incorporation or receptor binding, whereas substitution of glycine for the proline had only a nominal effect on EnvA function. Similar to other viral FPDs, the putative ASLV FPD has been modeled as an amphipathic helix where most of the bulky hydrophobic residues form a patch on one face of the helix. A series of alanine insertion mutations designed to interrupt the hydrophobic patch on the helix had differential effects on infectivity, and the results of that analysis together with the results observed with the substitution mutations suggest no correlation between maintenance of the hydrophobic patch and glycoprotein function.
Balliet
J W
JW
Department of Microbiology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6076, USA.
Gendron
K
K
Bates
P
P
D020816:Amino Acid Motifs; D000595:Amino Acid Sequence; D001354:Avian Leukosis Virus / Q000737:chemistry / Q000235:genetics / Q000472:pathogenicity; D001358:Avian Sarcoma Viruses / Q000737:chemistry / Q000235:genetics / Q000472:pathogenicity / Q000502:physiology; D002460:Cell Line; D004797:Enzyme-Linked Immunosorbent Assay; D000939:Epitopes; D008969:Molecular Sequence Data; D016254:Mutagenesis, Insertional; D009154:Mutation; D017354:Point Mutation; D011991:Receptors, Virus / Q000378:metabolism; D017384:Sequence Deletion; D014759:Viral Envelope Proteins / Q000737:chemistry* / Q000235:genetics* / Q000378:metabolism; D014771:Virion / Q000378:metabolism
D000939:Epitopes; D011991:Receptors, Virus; D014759:Viral Envelope Proteins